@FiercePharma: Wall Street sees Astellas nabbing OSI for up to $4.3 billion. Article | Follow @FiercePharma
The H1N1 flu pandemic is as severe as influenza pandemics in 1957 and 1968 and remains a threat to healthy young adults, John Mackenzie, the Australian who heads the World Health Organization's Emergency Committee, said Wednesday. Report
> India's Elder Pharmaceuticals aims to recruit 1,000 new sales and marketing employees over the next two months to launch a push into untapped rural markets. Report
> Shire has unveiled plans to use three exclusive wholesalers in the U.K. for such products as the bone drug Fosrenol and Alzheimer's remedy Reminyl. Report
> Indian drugmaker Ranbaxy Laboratories is voluntarily recalling at the retail level two lots of an oral suspension form of an antibiotic containing amoxicillin and clavulanate potassium. Report
> Russian Prime Minister Vladimir Putin approved a deal to sell a private insulin plant in the country to Sanofi-Aventis. Report
> A federal judge in Delaware has refused to dismiss a lawsuit accusing AstraZeneca of anticompetitive practices involving the heart drug Toprol-XL. Report
> Shares of Santarus slumped a day after the drug maker disclosed a U.S. federal judge ruled five patents for stomach drug Zegerid are invalid. Report
> Sigma Pharmaceuticals, the Australian drugmaker that lost half its market value after reporting a record loss last month, says CEO Elmo de Alwis has resigned. Report
Biotech News
@FierceBiotech: Positive MS data may thwart Icahn's plans for Genzyme. Story | Follow @FierceBiotech
@JohnCFierce: Agios gets $130M upfront in Celgene deal--now that's real money. | Follow @JohnCFierce
> Struggling Cell Therapeutics chops 36 workers. Story
> Third Rock raising $400 million venture fund for biotech "game-changers." Article
> Agios scores $130 million upfront from ambitious Celgene pact. Report
> Cambridge startup lands $25 million round for genetic sequencing play. Story
Manufacturing News
> Pfizer, GSK present at FDA's continuous processing symposium. Report
> Pall bullish on disposable filters, bioreactors. News
> Cold-chain solutions a must by 2014. Report
> Pharma industry, J&J drop in public opinion poll. Story
Vaccines News
> Oral vax provides big assist to patients with severe COPD. Item
> Personalized cancer vax heads to trial. Report
> HPV vax may prevent other cancers. News
> Dynavax shares spike on promising Heplisav data. Story
And Finally... Do estrogen's effects on women's minds and bodies depend heavily upon when they first start taking it? Report